These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10090781)

  • 1. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis.
    Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M
    J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxant activity in rat aorta and trachea, conversion to a muscarinic receptor antagonist and structure-activity relationships of new K(ATP) activating 6-varied benzopyrans.
    Lemoine H; Weber H; Derix A; Uhrig U; Höltje HD; Mannhold R
    Eur J Pharmacol; 1999 Jul; 378(1):85-97. PubMed ID: 10478568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
    Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
    Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
    Tyrrell E; Tesfa KH; Greenwood I; Mann A
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR studies on benzopyran potassium channel activators.
    Agrawal VK; Singh J; Gupta M; Jaliwala YA; Khadikar PV; Supuran CT
    Eur J Med Chem; 2006 Mar; 41(3):360-6. PubMed ID: 16458392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Sulfonylchromenes as highly potent K(ATP)-channel openers.
    Salamon E; Mannhold R; Weber H; Lemoine H; Frank W
    J Med Chem; 2002 Feb; 45(5):1086-97. PubMed ID: 11855989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives].
    Zhao SY; Huang WL; Zhang HB
    Yao Xue Xue Bao; 2002 Aug; 37(8):621-5. PubMed ID: 12567776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.
    Atwal KS; Ferrara FN; Ding CZ; Grover GJ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
    J Med Chem; 1996 Jan; 39(1):304-13. PubMed ID: 8568821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent.
    Thompson R; Doggrell S; Hoberg JO
    Bioorg Med Chem; 2003 Apr; 11(8):1663-8. PubMed ID: 12659752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
    Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
    J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
    Ding CZ; Rovnyak GC; Misra RN; Grover GJ; Miller AV; Ahmed SZ; Kelly Y; Normandin DE; Sleph PG; Atwal KS
    J Med Chem; 1999 Sep; 42(18):3711-7. PubMed ID: 10479302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
    Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
    J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxant activity of 4-amido-3,4-dihydro-2H-1-benzopyran-3-ols and 4-amido-2H-1-benzopyrans on guinea pig isolated trachealis.
    Buckle DR; Arch JR; Fenwick AE; Houge-Frydrych CS; Pinto IL; Smith DG; Taylor SG; Tedder JM
    J Med Chem; 1990 Nov; 33(11):3028-34. PubMed ID: 2231602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxant activity of 6-cyano-2,2-dimethyl-2H-1-benzopyran-4-carboxamides and -thiocarboxamides and their analogues in guinea pig trachealis.
    Arch JR; Buckle DR; Carey C; Parr-Dobrzanski H; Faller A; Foster KA; Houge-Frydrych CS; Pinto IL; Smith DG; Taylor SG
    J Med Chem; 1991 Aug; 34(8):2588-94. PubMed ID: 1875351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural modifications of benzanilide derivatives, effective potassium channel openers. X.
    Calderone V; Coi A; Fiamingo FL; Giorgi I; Leonardi M; Livi O; Martelli A; Martinotti E
    Eur J Med Chem; 2006 Dec; 41(12):1421-9. PubMed ID: 17030483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K(ATP)-channel openers.
    Carosati E; Lemoine H; Spogli R; Grittner D; Mannhold R; Tabarrini O; Sabatini S; Cecchetti V
    Bioorg Med Chem; 2005 Oct; 13(19):5581-91. PubMed ID: 16002299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing process.
    Florence X; Dilly S; de Tullio P; Pirotte B; Lebrun P
    Bioorg Med Chem; 2011 Jul; 19(13):3919-28. PubMed ID: 21664825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N'-(2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalim.
    Khelili S; Lebrun P; de Tullio P; Pirotte B
    Bioorg Med Chem; 2006 May; 14(10):3530-4. PubMed ID: 16455262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.